Pharmacodynamics of mivacurium in severely burned patients

Burns

Volumn 22, Issue 1, 1996, Pages 62-64

  Werba, A E ^a   Neiger, F X ^b   Bayer, G S ^b   Schultz, A M ^b   Maitz, P K M ^b   Wolrab, Ch ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; BURN; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG BURN; MALE; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS;

EID: 0030070320     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-4179(95)00065-8     Document Type: Article

References (16)

1. Coggeshall JW, Marini JJ, Newman JH. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Int Med 1985; 145: 1718.
2. Tomera JF, Martyn JAJ. Neuromuscular dysfunction and its relationship to burn size, hypermetabolism and immunosuppression. J Trauma 1988; 28: 1499.
3. Werba A, Klezl M, Schramm W, Langenecker S, Müller C, Gosch M, Spiss CK. The level of neuromuscular block needed to supress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia 1993; 48: 301.
4. Savarese JJ. Mivacurium: a comparison with other benzylisoquinolinium non-depolarising muscle relaxants. J Drug Dev 1993; 5: (suppl 1), 1.
5. Gronert GA, Theye RA. Pathophysiology of succinylcholine hyperkalemia. Anesthesiology 1975; 43: 89.
6. Dwersteg JF, Pavlin EG, Heimbach D. Burn patients are resistant to atracurium. Anesthesiology 1988; 65: 627.
7. Kim C, Fuke N, Martyn JAJ. Thermal injury to trunk of rats causes denervation-like responses in gastrocnemius muscle. Anesthesiology 1988; 68: 401.
8. Martyn JAJ. The use of neuromuscular relaxants in burn patients. Prob Anesth 1989; 3/3: 478.
9. Martyn JAJ, Abernethy DR, Greenblatt DJ. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther 1984; 35: 147.
10. Foldes FF, Nagashima H. Interactions of human cholinesterases and its binding to plasma proteins. Anesthesiology 1994; 81: A1062.
11. Demlin RH, LaLonde C. Burn Trauma. Trauma Management IV. Thieme: Blaisdell & Trunkey, 1989.
12. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 1988; 68: 723.
13. Frolich S. Serum cholinesterases deficiency in major burns. Burns 1977; 4: 123.
14. Viby-Morgensen, Hanel HK, Hansen E, Sorensen B, Graae J. Serum cholinesterase activity in burned patients I: biochemi-cal findings. Acta Anaesth Scand 1975; 19: 159.
15. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhoses. Br J Anaesth 1993; 71: 227.
16. Savarese JJ, Ali HH, Basta SJ et al. The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 1989; 70: 386.